Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Pacific Biosciences of California, Inc.    PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

(PACB)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/20/2020 11/23/2020 11/24/2020 11/25/2020 11/27/2020 Date
15.08(c) 14.93(c) 14.41(c) 14.54(c) 15.43(c) Last
2 101 554 3 064 263 2 801 431 1 471 334 2 327 714 Volume
-1.76% -0.99% -3.48% +0.90% +6.12% Change
More quotes
Financials (USD)
Sales 2020 75,6 M - -
Net income 2020 10,6 M - -
Net cash position 2020 199 M - -
P/E ratio 2020 273x
Yield 2020 -
Sales 2021 132 M - -
Net income 2021 -81,7 M - -
Net cash position 2021 126 M - -
P/E ratio 2021 -32,9x
Yield 2021 -
Capitalization 2 875 M 2 875 M -
EV / Sales 2020 35,4x
EV / Sales 2021 20,8x
Nbr of Employees 404
Free-Float 97,2%
More Financials
Company
Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell,... 
More about the company
All news about PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
11/13PACIFIC BIOSCIENCES OF CALIFORNIA, I : Entry into a Material Definitive Agreemen..
AQ
11/11PACIFIC BIOSCIENCES OF CALIFORNIA : Announces Pricing of Public Offering of Comm..
AQ
11/11Pacific Biosciences of California, Inc. Announces Pricing of Public Offering ..
GL
11/10PACIFIC BIOSCIENCES OF CALIFORNIA, I : Other Events, Financial Statements and Ex..
AQ
11/10PACIFIC BIOSCIENCES OF CALIFORNIA : Announces Proposed Public Offering of Common..
AQ
11/10Pacific Biosciences of California, Inc. Announces Proposed Public Offering of..
GL
11/10PACIFIC BIOSCIENCES OF CALIFORNIA, I : Change in Directors or Principal Officers..
AQ
11/03Arista, Cirrus rise; SolarEdge, Pacific Biosciences fall
AQ
11/03Arista, Cirrus rise; SolarEdge, Pacific Biosciences fall
AQ
11/03PACIFIC BIOSCIENCES OF CALIFORNIA : Management's Discussion and Analysis of Fina..
AQ
11/02PACIFIC BIOSCIENCES : 3Q Earnings Snapshot
AQ
11/02PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
AQ
11/02PACIFIC BIOSCIENCES OF CALIFORNIA : Announces Third Quarter 2020 Financial Resul..
AQ
11/02Pacific Biosciences of California, Inc. Announces Third Quarter 2020 Financia..
GL
10/22INVITAE : and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing..
AQ
More news
News in other languages on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
01/03WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
01/03WALL STREET STOCK EXCHANGE : USA-Les valeurs à suivre à Wall Street (actualisé)
2015PACIFIC BIOSCIENCES OF CALIFORNIA : stellt neue, auf seiner SMRT-Technologie bas..
2015PACIFIC BIOSCIENCES OF CALIFORNIA : lance une nouvelle plate-forme de séquençage..
2013PACIFIC BIOSCIENCES OF CALIFORNIA : publication des résultats trimestriels
More news
Chart PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Duration : Period :
Pacific Biosciences of California, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 14,00 $
Last Close Price 15,43 $
Spread / Highest target 3,69%
Spread / Average Target -9,27%
Spread / Lowest Target -22,2%
EPS Revisions
Managers
NameTitle
Christian O. Henry President, Chief Executive Officer & Director
John F. Milligan Chairman
Susan G. Kim Chief Financial Officer
Stephen W. Turner Chief Technology Officer
Jonas Korlach Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.200.19%2 875
CERNER CORPORATION0.97%22 718
PERKINELMER, INC.33.12%14 474
GN STORE NORD A/S60.04%10 378
BRUKER CORPORATION-0.61%7 756
LIFETECH SCIENTIFIC CORPORATION102.01%1 827